Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GENOSS-DAPT: 1 Month vs 12 Months DAPT in PCI
NCT05770674Recruiting
- Start
- Apr 2022
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin and clopidogrel in coronary artery disease (CAD) (2 arms). Primary endpoint: Net Adverse Clinical Event at 12 months. Started Apr 2022; status: recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05770674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05770674.